Please login to the form below

Not currently logged in
Email:
Password:

NovoMix 30

This page shows the latest NovoMix 30 news and features for those working in and with pharma, biotech and healthcare.

Novo Nordisk recalls insulin

Novo Nordisk recalls insulin

Novo Nordisk recalls insulin. Batches of prefilled NovoMix 30 pens found to have incorrect amount of diabetes treatment. ... Diabetes patients in Europe were warned to be on alert after Novo Nordisk announced a recall of several batches of its NovoMix

Latest news

  • The impact of insulin

    The company has modified the product into the more user-friendly formulations: NovoMix 30 is a dual-release insulin analog formulation of one rapid- and one intermediate-acting form of insulin ... aspart delivered in a single injection, and NovoMix 50

More from news
Approximately 1 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
wethepeople

wethepeople are bringing human appeal back to brand communications. Our approach allows us to create strategies, ideas and experiences that...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics